Pannex Therapeutics
Pannex Therapeutics is pioneering Pannexin 1 channel blockers, a breakthrough therapeutic class with significant potential in oncology and neurology.
- Stage Product In Development
- Industry Biotechnology
- Location New York, NY, USA
- Currency USD
- Founded May 2021
- Employees 3
- Incorporation Type C-corp
- Website pannextherapeutics.com
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.